| Breakdown | TTM | Mar 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 18.87B | 19.48B | 18.64B | 15.81B | 16.38B | 16.13B |
| Gross Profit | 2.24B | 2.22B | 2.07B | 1.90B | 2.44B | 2.93B |
| EBITDA | 2.18B | 2.20B | 2.38B | 839.00M | 2.08B | 2.36B |
| Net Income | 858.00M | 791.00M | 820.00M | -1.00B | 922.00M | 1.58B |
Balance Sheet | ||||||
| Total Assets | 25.24B | 28.80B | 24.78B | 25.12B | 24.90B | 22.47B |
| Cash, Cash Equivalents and Short-Term Investments | 2.75B | 4.85B | 2.77B | 2.25B | 2.39B | 3.42B |
| Total Debt | 5.53B | 6.92B | 5.45B | 6.35B | 4.72B | 3.99B |
| Total Liabilities | 10.11B | 12.44B | 9.93B | 10.58B | 9.72B | 8.19B |
| Stockholders Equity | 15.12B | 16.36B | 14.86B | 14.54B | 15.18B | 14.28B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.75B | 1.86B | -1.71B | -1.59B | -342.00M |
| Operating Cash Flow | 0.00 | 2.58B | 2.75B | 1.05B | 404.00M | 1.15B |
| Investing Cash Flow | 0.00 | -1.84B | -1.19B | -2.67B | -2.00B | -1.52B |
| Financing Cash Flow | 0.00 | 1.33B | -1.03B | 1.48B | 563.00M | 543.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥45.18B | 8.51 | ― | 3.53% | -7.83% | 13.79% | |
63 Neutral | ¥17.89B | 21.99 | ― | 1.81% | 4.46% | -3.54% | |
63 Neutral | ¥13.95B | 10.79 | ― | 3.89% | -0.65% | -0.09% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
53 Neutral | ¥16.40B | -20.11 | ― | ― | -50.03% | -612.74% | |
43 Neutral | ¥10.12B | 33.67 | ― | 1.06% | -7.88% | 129.32% |